Peptitek Research

WELCOME OFFER: SAVE 40% ON YOUR FIRST ORDER!

Get 40% Off Your First Order — Use Code: Save40

CJC-1295 no DAC 10mg

CJC-1295 (No DAC), commonly known as Modified GRF (1-29), is a synthetic 29-amino-acid peptide analog of growth hormone-releasing hormone (GHRH), supplied for controlled laboratory research involving GHRH receptor pharmacology, peptide-receptor interactions, molecular signaling pathways, ligand-binding characteristics, and related biochemical studies. Researchers should confirm the exact material form, salt state, purity, concentration, and storage requirements through the product label and lot-specific documentation.

CJC-1295 (No DAC) is structurally derived from the first 29 amino acids of human growth hormone-releasing hormone and contains four amino acid substitutions at positions 2, 8, 15, and 27. These modifications include D-alanine, glutamine, alanine, and leucine substitutions, respectively. Unlike CJC-1295 with DAC, this peptide lacks the drug-affinity complex or albumin-binding modification. The free peptide has the molecular formula C₁₅₂H₂₅₂N₄₄O₄₂ and a molecular weight of approximately 3367.9 g/mol.

$ 60

The exact molecular formula and molecular weight may vary when CJC-1295 (No DAC) is supplied as an acetate, trifluoroacetate, hydrate, or another salt form. Researchers should therefore verify the specific material designation, counterion composition, and analytical specifications listed on the Certificate of Analysis before performing molecular calculations or preparing experimental protocols.

Within controlled research environments, CJC-1295 (No DAC) may be studied in experimental models involving GHRH receptor interactions, peptide-binding characteristics, intracellular signaling mechanisms, structural modifications, ligand-receptor recognition, and peptide stability. Comparative research may also examine differences between modified GHRH analogs and their structural characteristics under defined biochemical conditions.

Establish experimental parameters independently for each protocol. Researchers should assess solvent compatibility, concentration, pH, peptide stability, analytical methodology, temperature sensitivity, storage conditions, and potential material interactions before incorporating CJC-1295 (No DAC) into a research workflow.

Research Applications

CJC-1295 (No DAC) may support controlled laboratory studies involving:

  • Growth hormone-releasing hormone receptor research
  • Peptide-receptor interaction studies
  • GHRH receptor-binding analysis
  • Molecular signaling pathway research
  • Structure-activity relationship studies
  • Ligand-receptor interaction analysis
  • Synthetic peptide characterization
  • Comparative GHRH analog research
  • Analytical method development
  • Peptide stability and degradation investigations

Storage and Handling

Store CJC-1295 (No DAC) according to the conditions specified on the product label, Certificate of Analysis, or accompanying technical documentation. Protect the material from excessive heat, moisture, direct light, and unnecessary environmental exposure. Storage requirements may differ depending on the peptide’s physical form, salt composition, and formulation characteristics.

For lyophilized material, keep the container securely sealed until required for controlled laboratory preparation. Once prepared in solution, stability may depend on solvent composition, concentration, temperature, pH, container material, and storage duration. Researchers should evaluate these conditions through appropriate stability assessments and validated analytical procedures.

Avoid repeated temperature fluctuations where possible. Use appropriate laboratory handling procedures and maintain accurate records of preparation dates, storage conditions, material identification, lot numbers, and analytical use. Follow documented laboratory protocols to support consistent material handling and experimental reproducibility.

Product Specifications

Product Name: CJC-1295 (No DAC)

Alternative Names: Modified GRF (1-29), Mod GRF 1-29, CJC-1295 Without DAC

Product Category: Synthetic GHRH analog peptide

Peptide Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

Peptide Length: 29 amino acid residues

CAS Number: 863288-34-0 (commonly referenced; confirm against product-specific documentation)

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂ (free peptide)

Molecular Weight: Approximately 3367.9 g/mol (free peptide)

Structural Modification: D-Ala², Gln⁸, Ala¹⁵, Leu²⁷ substitutions; C-terminal amidation; no DAC modification

Material Form: Verify through lot-specific documentation

Salt Form: Verify through product-specific documentation

Appearance: Typically supplied as a lyophilized research material; confirm lot-specific documentation

Purity: Refer to lot-specific Certificate of Analysis

Container Type: Sealed research vial or product-specific container

Testing Documentation: Lot-specific analytical records, where provided

Intended Setting: Controlled laboratory research

Use Classification: Research use only

Human or Veterinary Use: Prohibited

Quality Assurance

Each lot of CJC-1295 (No DAC) should include appropriate product-specific documentation, where available. Analytical records may include identity confirmation, purity assessment, chromatographic analysis, mass-spectrometric results, molecular specifications, batch identification, and recommended storage conditions. These records support material characterization and traceability within controlled laboratory research environments.

Researchers should verify that the stated peptide sequence, molecular formula, molecular weight, salt form, purity, and lot number correspond with the Certificate of Analysis before beginning experimental work. Analytical documentation should also confirm that the supplied material matches the No DAC peptide structure rather than the DAC-modified variant, as these are chemically distinct materials.

Because molecular specifications may differ between the free peptide and acetate, trifluoroacetate, or other salt forms, lot-specific documentation should serve as the primary reference for analytical calculations, material identification, and experimental recordkeeping. Accurate verification of peptide identity and physicochemical characteristics supports consistency across research procedures and analytical evaluations.

Research Use Disclaimer

For laboratory research use only. Not for human or veterinary use. Not intended for injection, administration, diagnosis, treatment, cure, or prevention of any disease. Do not use this research product as a food, drug, cosmetic, dietary supplement, or household product.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 no DAC 10mg”

Your email address will not be published. Required fields are marked *

Related Products
×

WELCOME OFFER: SAVE 40% ON YOUR FIRST ORDER!

Get 40% Off Your First Order — Use Code: Save40

Scroll to Top